Johnson & Johnson may outshine AbbVie as a top defensive stock pick. Read how Ben Graham's framework evaluates each ...

Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

In this article, we will take a look into Johnson & Johnson's (NYSE:JNJ) DCF analysis, a reliable and data-driven approach to ...

Johnson & Johnson (NYSE:JNJ – Get Free Report) was the target of some unusual options trading on Thursday. Stock traders purchased 58,414 call options on the stock. This is an increase of ...

KLCM Advisors Inc. grew its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 2.0% in the fourth quarter, ...

Kenvue (NYSE: KVUE) stock is down since completing its spin-off from Johnson & Johnson (NYSE: JNJ) in August 2023. Kenvue is ...

We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital initiated coverage with a Buy rating on Johnson & Johnson (JNJ – ...

We recently published a list of 10 Best Spin Off Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Johnson & Johnson (JNJ) closed the latest trading day at $157.89, indicating a +1.87% change from the previous session's end. This move outpaced the S&P 500's daily gain of 0.24%. At the same time, ...